![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 28, 2006.
Revised September 6, 2006.
Accepted for publication September 7, 2006.
To determine the role of C-Rel in nitric oxide synthase-2 (NOS-2) transcriptional activation, we evaluated the effect of lipopolysaccharide and interferon-
(LPS/IFN
) on C-Rel DNA binding in RAW 264.7. LPS/IFN
-stimulated C-Rel binding peaked at 4-8 h and declined at 24 h. Transfection of cells with a C-Rel small interfering RNA abrogated C-Rel binding at all time points. LPS/IFN
produced superoxide at 4 h which subsided at 8 h. C-Rel binding and NOS-2 expression were abrogated by superoxide dismutase or apocynin at 4 h, suggesting a key role that superoxide plays in mediating C-Rel binding and NOS-2 transactivation only at 4 h. We have previously reported that salicylate at 10-5 M inhibited LPS/IFN
-induced C/EBP
binding at 4 h but not at 8 h or 24 h. A single dose of salicylate did not inhibit C-Rel binding at any time point. Addition of a second dose of salicylate 4 h prior to an indicated end point suppressed C-Rel but not C/EBP
or IRF-1 binding at 8 h and 24 h. A single dose of salicylate added with LPS/IFN
inhibited NOS-2 expression only at 4 h. However, salicylate supplement inhibited NOS-2 promoter activities, mRNA and protein levels throughout 24 h. Signal profiling with a panel of inhibitors revealed time-dependent switch of signaling pathways. These results demonstrate temporal regulation of transactivator binding by LPS/IFN
via evolving signaling pathways. We propose that salicylate inhibits C/EBP
binding at 4 h and C-Rel binding at 8 h and 24 h by targeting related kinases.
Key words:
Prostanoid, Nitric oxide, Nitric oxide synthases, P38 MAP Kinase, NFkappaB, Cyclooxygenases, RNA/siRNA
This article has been cited by other articles:
![]() |
Z. T. Kelleher, A. Matsumoto, J. S. Stamler, and H. E. Marshall NOS2 Regulation of NF-{kappa}B by S-Nitrosylation of p65 J. Biol. Chem., October 19, 2007; 282(42): 30667 - 30672. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-G. Deng, A. J. Montero, and K. K. Wu Interferon-{gamma} Suppresses Cyclooxygenase-2 Promoter Activity by Inhibiting C-Jun and C/EBP{beta} Binding Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1752 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta} Circ. Res., March 16, 2007; 100(5): e59 - e71. [Abstract] [Full Text] [PDF] |
||||